INTUITIVE SURGICAL $510.00

up +0.39


19/6/2013 04:19 PM  |  NASDAQ : ISRG  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Last Trade: 510.00
Trade Time: Jun 19 4:04 PM Eastern Daylight Time
Change: 0.39 (0.08 %)
Prev Close: 509.61
Open: 510.50
Bid: 504.10
Ask: 526.01
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get ISRG Trend Analysis - it has underperformed the S&P 500 by 28%

ETF Alternatives



People viewing ISRG also viewed: , , , ,

Competitors

Ticker Name Volume % Change
CPCF CPC OF AMERICA; INC. 1.6K +0.65%
RMCP REVOLUTIONS MEDICAL 789.2K +0.41%
DYXC DIASYS 20.0K +0.25%
SPHE SPEARHEAD LIMITED 55.0K +0.25%
CYOE CYTOCORE 54.8K +0.20%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
3/4/2013 SMITH LONNIE M Chairman of the Board 13,750 $107.27 5.70%
3/4/2013 SMITH LONNIE M Chairman of the Board 11,250 $303.27 4.66%
3/4/2013 SMITH LONNIE M Chairman of the Board -11,250 $541.43 -4.46%
3/4/2013 SMITH LONNIE M Chairman of the Board -13,750 $541.43 -5.39%
3/1/2013 Brogna Salvatore SVP Product Development -1,094 $553.00 -68.85%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ISRG), click here.

ISRG Stock Analysis

  1. Mindray to Takeover ZONARE - Analyst Blog

    Mindray Medical International Limited recently reported a definitive agreement to takeover ZONARE Medical Systems, Inc.
  2. Masimo Wins a Major Client - Analyst Blog

    Masimo reported that the University Children's Hospital, Basel was the first pediatric institution in the region to utilize Masimo Patient SafetyNet.
  3. It Gets A Little Harder From Here For Covidien

    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  4. Is Controversy About Robot-Assisted Surgery Showing In Intuitive Surgical's Numbers?

    Uncertainty about procedure growth may be opening a window in these often-expensive shares
  5. Pharma Is Doing All The Pulling For Johnson & Johnson

    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
Free Reports
  1. Stock Ideas From Warren Buffett

    Access Coattail Investor’s latest free report and get two investing ideas from Warren Buffett himself!
  2. Get 10 Trading Lessons FREE

    Benefit from the knowledge of MarketClub co-founder Adam Hewison and our other trading experts, with this FREE series of educational emails and online content.
  3. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
Marketplace
Trading Center